🇺🇸 FDA
Patent

US 7175843

Methods for selectively stimulating proliferation of T cells

granted A61KA61K40/11A61K40/46

Quick answer

US patent 7175843 (Methods for selectively stimulating proliferation of T cells) held by United States of America as represented by the Secretary of the Air Force expires Mon Feb 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States of America as represented by the Secretary of the Air Force
Grant date
Tue Feb 13 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
65
CPC classes
A61K, A61K40/11, A61K40/46